NCT03791034View on ClinicalTrials.gov

Cell Free DNA for the Diagnosis and Treatment in Early NSCLC

RecruitingOBSERVATIONAL

Enrollment

700

Participants

Timeline

Start Date

August 28, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2026

Conditions

Non-small Cell Lung Cancer

Trial Locations (1)

06351

RECRUITING

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

Guardant Health, Inc.

All Listed Sponsors

collaborator

Guardant Health, Inc.

INDUSTRY

lead

Samsung Medical Center

OTHER

NCT03791034 - Cell Free DNA for the Diagnosis and Treatment in Early NSCLC | Biotech Hunter | Biotech Hunter